Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Quantitative analysis of cerebrospinal fluid brain derived neurotrophic factor in the patients with multiple sclerosis.
Neuromyelitis optica presenting as intractable vomiting and hyperCKaemia.
T cell repertoire following autologous stem cell transplantation for multiple sclerosis.
Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis.
Canadian Experience with Fingolimod: Adherence to Treatment and Monitoring.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
Central auditory processing and word discrimination in patients with multiple sclerosis.
Care patterns in multiple sclerosis: principal care, comprehensive team care, consortium care.
Expression Profile of Long Non-Coding RNAs in Serum of Patients with Multiple Sclerosis.
ASP4058, a Novel Agonist for Sphingosine 1-Phosphate Receptors 1 and 5, Ameliorates Rodent Experimental Autoimmune Encephalomyelitis with a Favorable Safety Profile.
Modulation of multiple sclerosis by sunlight exposure: Role of cis-urocanic acid.
Dietary phytochemicals and neuro-inflammaging: from mechanistic insights to translational challenges.
Promotion of Remyelination by Sulfasalazine in a Transgenic Zebrafish Model of Demyelination.
A spring to summer shift of pro-inflammatory cytokine production in multiple sclerosis patients.
Iron depletion induced by bloodletting and followed by rhEPO administration as a therapeutic strategy in progressive multiple sclerosis: A pilot, open-label study with neurophysiological measurements.
Hyaluronidase and Hyaluronan Oligosaccharides Promote Neurological Recovery after Intraventricular Hemorrhage.
P300 wave changes in patients with multiple sclerosis.
Paroxysmal dysarthria-ataxia syndrome resolving after fingolimod treatment.
Teaching NeuroImages: Cerebral white matter involvement in a patient with Vogt-Koyanagi-Harada syndrome.
[Oral disease-modifying agents in relapsing-remitting multiple sclerosis].
Comment on: 'Prevalence of brain magnetic resonance imaging meeting Barkhof and McDonald criteria for dissemination in space among headache patients'
Catatonia and klüver-bucy syndrome in a patient with acute disseminated encephalomyelitis.
Predicting relapsing-remitting dynamics in multiple sclerosis using discrete distribution models: a population approach.
Clinical and cognitive implications of cerebrospinal fluid oligoclonal bands in multiple sclerosis patients.
Consistent reduction in the annualized rate of brain volume loss across phase 3 core and extension trials of fingolimod in relapsing multiple sclerosis.
Pages
« first
‹ previous
…
585
586
587
588
589
590
591
592
593
…
next ›
last »